Showing results (211-220 of 752) with videos related to
Sort By:
Pageof 76
Journal of Neuro-Oncology|April 18, 2014
The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guidelineJeffrey J Olson, Lakshmi Nayak, D Ryan Ormond, et al.The Journal of Supportive Oncology|August 12, 2005
Suspected spinal cord compression in cancer patients: a multidisciplinary risk assessmentCharles Lu, Ramon G Gonzalez, Ferenc A Jolesz, et al.Expert Opinion on Biological Therapy|March 21, 2008
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapyDavid A Reardon, Patrick Y Wen, Annick Desjardins, et al.Journal of Neuro-Oncology|February 18, 2009
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progressionElizabeth R Gerstner, Margaret B McNamara, Andrew D Norden, et al.Biomedical Chromatography : BMC|August 8, 2022
Development and validation of a liquid chromatography coupled with tandem mass spectrometry method for determining total and unbound pamiparib in human plasma and brain tumorsJun Jiang, Xun Bao, Yang Yue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiformeJan Drappatz, Eric T Wong, David Schiff, et al.Neuro-Oncology|August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progressionRaymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.Neuro-Oncology Practice|April 8, 2020
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member surveyJames L Rogers, Alvina Acquaye, Elizabeth Vera, et al.Pageof 76